Real-time PCR for HER-2/neu Status in Breast Cancer
Author Information
Author(s): Nistor Andreea, Watson Peter H, Pettigrew Norman, Tabiti Karim, Dawson Angelika, Myal Yvonne
Primary Institution: University of Manitoba
Hypothesis
Does real-time PCR provide an accurate alternative for determining HER-2/neu status compared to FISH?
Conclusion
Real-time PCR analysis using the LightCycler is a viable alternative to FISH for evaluating breast tumors with indeterminate IHC scores.
Supporting Evidence
- The study found a 92% concordance between FISH and real-time PCR results.
- 10% of tumors were positive for gene amplification by both methods.
- Real-time PCR is simpler and faster than FISH.
Takeaway
This study shows that a new test called real-time PCR can help doctors check if a breast cancer patient has a specific gene that can affect treatment, and it works well compared to the older test.
Methodology
The study compared the results of real-time PCR and FISH on 39 breast tumors with an IHC score of 2+.
Limitations
The study focused only on tumors with an indeterminate IHC score, which may limit the generalizability of the findings.
Statistical Information
P-Value
0.0009
Confidence Interval
95%
Statistical Significance
p < 0.0009
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website